OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C
OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C Kurs - 1 Jahr
Baader Bank gettex Düsseldorf Lang & Schwarz München Stuttgart Tradegate XETRA QuotrixWichtige Stammdaten
Emittent | OSSIAM |
Auflagedatum | 10.11.2017 |
Kategorie | Aktien |
Fondswährung | EUR |
Benchmark | |
Ausschüttungsart | Thesaurierend |
Total Expense Ratio (TER) | 0,17 % |
Fondsgröße | 303.116.153,12 |
Replikationsart | Physisch vollständig |
Morningstar Rating | - |
Anlageziel OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR
So investiert der OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR: The investment objective of the Fund is to replicate, before the Fund's fees and expenses, the performance of the Bloomberg PAB Europe DM ex Eurozone Large & Mid Cap Net Return Index (the “Index”, ticker: EUXPABNL) closing level. The Fund is a financial product that pursuant to Article 9(3) of Regulation (EU) 2019/2088 of the European Parliament and of the Council of 27 November 2019 on sustainability-related disclosures in the financial services sector (the “SFDR”) has the objective of reducing carbon emissions in view of achieving the long-term global warming objectives of the Paris Agreement through the replication of the Index. The Index is a Bloomberg Global Equity Paris-Aligned Index expressed in EUR, calculated and published by Bloomberg (the "Index Provider"). The anticipated level of tracking error in normal conditions is 1.00% over a one-year period.
Der OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR gehört zur Kategorie "Aktien".
Wertentwicklung (NAV) WKN: A2DVG2
3 Monate | 6 Monate | 1 Jahr | 3 Jahre | 5 Jahre | 2025 | |
---|---|---|---|---|---|---|
Performance | -2,26 % | +3,11 % | +1,69 % | +32,19 % | +60,24 % | +3,71 % |
Outperformance ggü. Kategorie | -3,83 % | +0,40 % | -2,97 % | +5,73 % | +15,18 % | +0,07 % |
Max Verlust | - | - | -10,98 % | -18,76 % | -25,57 % | - |
Kurs | - | - | - | - | - | 167,22 € |
Hoch | - | - | 177,04 € | - | - | - |
Tief | - | - | 146,75 € | - | - | - |
Kennzahlen ISIN: LU1655103486
Name | 1 Jahr | 3 Jahre | 5 Jahre | 10 Jahre |
---|---|---|---|---|
Volatilität | 11,08 % | 13,49 % | 12,77 % | |
Sharpe Ratio | +0,28 | +0,39 | +0,78 |
Zusammensetzung WKN: A2DVG2
Größte Positionen ISIN: LU1655103486
Name | ISIN | Marktkapitalisierung | Gewichtung |
---|---|---|---|
Nestle SA | CH0038863350 | 218.792.515.468 € | 5,61 % |
Novartis AG Registered Shares | CH0012005267 | 191.026.148.613 € | 4,94 % |
AstraZeneca PLC | GB0009895292 | 188.165.094.816 € | 4,86 % |
Novo Nordisk AS Class B | DK0062498333 | 283.290.162.888 € | 4,72 % |
Roche Holding AG | CH0012032048 | 218.806.999.792 € | 4,67 % |
HSBC Holdings PLC | GB0005405286 | 176.972.512.961 € | 3,98 % |
Unilever PLC | GB00B10RZP78 | 130.782.911.490 € | 3,17 % |
RELX PLC | GB00B2B0DG97 | 83.470.872.192 € | 2,19 % |
Zurich Insurance Group AG | CH0011075394 | 83.837.728.400 € | 2,15 % |
Compagnie Financiere Richemont SA Class A | CH0210483332 | 92.282.801.508 € | 1,75 % |
Summe Top 10 | 38,04 % |
Weitere ETFs mit gleicher Benchmark
ETF | TER | Größe | Perf 1J |
---|---|---|---|
OSSIAM BLOOMBERG EUROPE ex EUROZONE PAB NR 1C EUR | 0,17 % | 303,12 Mio. € | +1,69 % |
iShares MSCI USA ESG Enhanced CTB UCITS ETF EUR Hedged Acc | 0,10 % | 17,46 Mrd. € | +7,80 % |
Xtrackers II EUR Overnight Rate Swap UCITS ETF 1C | 0,10 % | 17,27 Mrd. € | +3,06 % |
Amundi Index Solutions - Amundi EUR Corporate Bond ESG UCITS ETF 2 DR - EUR (C) | 0,14 % | 6,32 Mrd. € | +5,74 % |
Vanguard FTSE Developed Europe UCITS ETF EUR Accumulation | 0,10 % | 5,13 Mrd. € | +7,30 % |